Moderna’s launch of a COVID-19 vaccine and its approval for use in the United States, Canada and the European Union capped off what can only be described as a wild year. Behind the scenes, what unfolded was nothing short of a digital revolution in the biopharmaceutical industry. For other industries and the manufacturing sector in general, this success story is also a case study demonstrating the benefits of digital transformation.
We’re all digital in our genes
Perhaps it shouldn’t be surprising that digital transformation makes sense for the pharmaceutical industry. After all, our genetic information is literally digitally transcribed in our DNA, with base pairs adenine-thymine (A-T) and cytosine-guanine (C-G) acting as zeros and ones. If you need a quick refresher on high school biology, check out this article.